IDEXX LABORATORIES INC /DE Operating Lease, Liability, Noncurrent
IDEXX LABORATORIES INC /DE (IDXX) had Operating Lease, Liability, Noncurrent of $100.50 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-04
- 2026-06-30: Operating Lease, Liability, Noncurrent $100.50M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $98.75M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $101.15M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $106.49M.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2026-06-30 | $100.50M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $98.75M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $101.15M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $106.49M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $107.64M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $97.00M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $97.84M 10-K · filed 2026-02-20 |
| 2024-09-30 | $103.42M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $102.97M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $103.88M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $99.67M 10-K · filed 2025-02-21 |
| 2023-09-30 | $101.47M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $97.34M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $98.18M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $101.24M 10-K · filed 2024-02-22 |
| 2022-09-30 | $93.13M 10-Q · filed 2022-11-01 |
| 2022-06-30 | $98.04M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $89.63M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $87.38M 10-K · filed 2023-02-16 |
| 2021-09-30 | $89.72M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $88.33M 10-Q · filed 2021-07-30 |
| 2021-03-31 | $78.19M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $77.04M 10-K · filed 2022-02-16 |
| 2020-09-30 | $70.66M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $68.60M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $65.34M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $67.47M 10-K · filed 2021-02-12 |
| 2019-09-30 | $66.34M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $69.33M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $68.95M 10-Q · filed 2019-05-01 |
| 2019-01-01 | $68.94M 10-K · filed 2020-02-14 |
| 2018-12-31 | $0.00 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |